Meet an M2D2 Finalist: MAG Optics

MAG Optics is a finalist in the 7th annual M2D2 $200K Challenge.

Geeta Singh of MAG Optics

MAG Optics is one of 20 finalists in the 7th annual M2D2 $200K ChallengeGeeta Singh, Co-founder and Chief Business Officer, shares the story of their innovation.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

MAG Optics is pioneering an intra-corneal implant, MAGarcs, that is the first patient-centric corneal shape-changing platform to address keratoconus, a rare degenerative disease characterized by a cone-shaped cornea.   Continue reading

Innovation in Spine Surgery—Evidence-Based Medicine. Attend the panel discussion at UMass Medical on April 6.

The panel discussion will focus on innovation in spine surgery to improve clinical outcomes. Considering the complex spinal pathology, spine surgeons leverage different technologies and techniques to achieve a safe and efficacious clinical outcome. Researchers and clinicians with a multi-disciplinary background will share their scientific data with all spine specialists. Continue reading

Meet an M2D2 Finalist: AMProtection

AMProtection is a finalist in the M2D2 $200K Challenge.

Dr. Lindsey Lozeau and Todd E. Alexander of AMProtection

Introducing AMProtection, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder Todd Alexander shared the story of their innovation and its development so far. 

What is the innovation you’ve entered in the M2D2 $200K Challenge?

AMProtection provides platform antimicrobial coatings to prevent medical device-associated infections without promoting bacterial resistance. Continue reading

Meet an M2D2 Finalist: Drug Free Therapeutix

Drug Free Therapeutix is a finalist in the 7th annual M2D2 $200k Challenge.

Clockwise from top left: Stephen Hourigan, CEO/Co-Founder; John Ward, President/Co-Founder; Matthew Ward, CSO/Co-Founder; Shreyas Sen, CTO/Co-Founder

Meet Drug Free Therapeutix, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder and CSO Matthew Ward took us inside the development of their innovation. 

What is the innovation you’ve entered in the M2D2 $200K Challenge?

DFTx empowers next-generation bioelectronics for pain and other conditions through machine learning and human body communication technology. Continue reading

Meet an M2D2 Finalist: 3D Tumor Targeting

Huanchen Li of 3D Tumor Targeting is a finalist in the 7th Annual M2D2 $200K Challenge.

Huanchen Li of 3D Tumor Targeting

3D Tumor Targeting is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Founder Huanchen Li described his innovation and shared the story behind it.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

With external magnets, we manipulate in vivo diamagnetic nanoparticles in a 3D manner into tumors, then heat the nanoparticles to destroy the tumors. Continue reading

Meet an M2D2 Finalist: Sleep Systems

Chris Lyons is Founder and CTO of Sleep Systems, an M2D2 $200K Challenge Finalist.

Chris Lyons of Sleep Systems

Sleep Systems is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Founder and CTO Chris Lyons told us about how their innovation came about and the company’s future vision.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

Sleep Systems has developed a new methodology and a non-intrusive in-the-ear device to treat obstructive sleep apnea (OSA). Continue reading

Meet an M2D2 Finalist: Accelera

Accelera is a finalist in the M2D2 $200K Challenge.

Clockwise from top left: Michael Wing, Co-Founder, President, and COO; Karin Gregory, Co-Founder, Legal & Regulatory; James Niemi, CTO; Heather Keith, Sales & Marketing

Introducing Accelera, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. We spoke with co-founder, president, and COO Michael Wing who shared the story of their innovation.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

Accelera’s first wearable technology product is a soft personal ankle wrap embedded with patented Stochastic Resonance Stimulation (SRS) technology. It is adjustable to the individual to create a safe-to-use, low-level stimulation that restores the body’s natural level of sensitivity, leading to improved proprioception, balance, postural stability, and gait.   Continue reading

Meet an M2D2 $200K Challenge Finalist: NERv Technology, Inc.

Amr Abdelgawad is co-founder and COO of NERv Technology, Inc., a finalist in the 7th annual M2D2 $200K Challenge.

Amr Abdelgawad of NERv Technology, Inc.

NERv Technology, Inc. is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder and COO Amr Abdelgawad explains how they’ve developed and advanced their idea.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

NERv is developing an implantable biochip to detect anastomotic leakage, the leakage of gastrointestinal fluid into the abdominal cavity, in real-time. Continue reading

Meet an M2D2 $200K Challenge Finalist: Prapela

John Konsin is co-founder and CEO of Prapela, an M2D2 $200K Challenge Finalist.

John Konsin of Prapela

Prapela is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. To learn more about their innovation, we interviewed John Konsin, Prapela co-founder and CEO.

What is the innovation you’ve entered in the M2D2 $200K Challenge?

Prapela is an infant sleep tech company integrating stochastic vibro-tactile technology into medical and consumer products that help newborns breathe and relax.

Continue reading

Meet an M2D2 $200K Challenge Finalist: Cam Med LLC

Larry Alberts is a co-founder of Cam Med LLC, a finalist in the 7th annual M2D2 $200K Challenge

Larry Alberts of Cam Med LLC

Cam Med LLC is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder Larry Alberts tells us about their idea and the story behind it.

What is the innovation you’ve entered in the M2D2 $200K Challenge?
Like a bandage yet actively controllable, the Evopump will greatly improve compliance for people frequently taking injectable medications.

Continue reading